scholarly journals Primary vascular bone tumors in the spine: a challenge for pathologists and spine oncology surgeons

2019 ◽  
Vol 28 (6) ◽  
pp. 1502-1511 ◽  
Author(s):  
Stefano Boriani ◽  
Riccardo Cecchinato ◽  
Alberto Righi ◽  
Stefano Bandiera ◽  
Angelo Paolo Dei Tos ◽  
...  
Open Medicine ◽  
2012 ◽  
Vol 7 (1) ◽  
pp. 73-77
Author(s):  
Evi Vassalou ◽  
Evangelos Perdikakis ◽  
Elpida Giannikaki ◽  
Dimitris Mavroudis ◽  
Pavlos Katonis ◽  
...  

AbstractPrimary malignant vascular bone tumors are unusual and include hemangioendothelioma, epitheloid hemangioendothelioma and angiosarcoma. Although few cases of primary bone angiosarcomas have been reported, those of femoral origin are even more infrequent. Such tumors diagnosis may be challenging due to their radiographic and histologic variety. We present a case of a 24-yearold woman with a subperiosteal diaphyseal angiosarcoma originating from the femoral bone and metastatic to the lung at the time of diagnosis. The clinical, histological and radiological features of this extremely rare lesion are presented.


2019 ◽  
Vol 28 (10) ◽  
pp. 2433-2433
Author(s):  
Stefano Boriani ◽  
Riccardo Cecchinato ◽  
Alberto Righi ◽  
Stefano Bandiera ◽  
Angelo Paolo Dei Tos ◽  
...  

Author(s):  
G. Scott Stacy

The classification of vascular tumors of the skeleton can be thought of as a spectrum of disease including both benign and malignant entities. Chapter 60 focuses on the benign entities, hemangioma and epithelioid hemangioma. The term hemangioma refers to a collection of blood vessels and vascular spaces, perhaps better classified as a slow-flow vascular malformation. Epithelioid hemangioma is a rare and controversial entity that may be confused with its malignant counterpart, the epithelioid hemangioendothelioma. This chapter will describe the clinical, pathophysiological, and imaging features of these benign vascular bone tumors, with a brief mention of treatment strategies. Familiarity with the imaging appearances and characteristics of these entities is essential in order to guide clinical management and to avoid unnecessary investigation into clearly benign lesions.


Author(s):  
G. Scott Stacy

The organization of vascular bone tumors can be thought of as a spectrum of disease including both benign and malignant entities. Chapter 61 focuses on the malignant tumors, which have elicited much controversy and debate. These include 2 vascular tumors of bone recognized by the World Health Organization: epithelioid hemangioendothelioma and angiosarcoma. Although there are no characteristic imaging features that would obviate the need for biopsy of these entities, they may present with multifocal bone lesions, which can suggest the diagnosis of a vascular tumor. This chapter will describe the clinical, pathophysiological, and imaging features of these malignant vascular bone tumors, with a brief mention of treatment strategies.


2012 ◽  
Vol 41 (12) ◽  
pp. 1495-1507 ◽  
Author(s):  
Costantino Errani ◽  
Daniel Vanel ◽  
Marco Gambarotti ◽  
Marco Alberghini ◽  
Piero Picci ◽  
...  

1994 ◽  
Vol 13 (4) ◽  
pp. 909-938 ◽  
Author(s):  
Arthur K. Walling ◽  
Seth I. Gasser

1982 ◽  
Vol 21 (04) ◽  
pp. 136-139 ◽  
Author(s):  
C.-J. Edeling

Whole-body scintigraphy with both 99mTc-phosphonate and 67Ga was performed on 92 patients suspected of primary bone tumors. In 46 patients with primary malignant bone tumors, scintigraphy with 99mTc-phosphonate disclosed the primary tumor in 44 cases and skeletal metastases in 11, and 67Ga scintigraphy detected the primary tumor in 43 cases, skeletal metastases in 6 cases and soft-tissue metastases in 8 cases. In 25 patients with secondary malignant bone tumors, bone scintigraphy visualized a single lesion in 10 cases and several lesions in 15 cases, and 67Ga scintigraphy detected the primary tumor in 17 cases, skeletal metastases in 17 cases and soft-tissue metastases in 9 cases. In 21 patients with benign bone disease positive uptake of 99mTc-phosphonate was recognized in 19 cases and uptake of 67Ga in 17 cases. It is concluded that bone scintigraphy should be used in patients suspected of primary bone tumors. If malignancy is suspected, 67Ga scintigraphy should be performed in addition.


2018 ◽  
Author(s):  
Alexandra Gersing ◽  
Daniela Muenzel ◽  
Felix Kopp ◽  
Benedikt Schwaiger ◽  
Carolin Knebel ◽  
...  

2019 ◽  
Vol 65 (2) ◽  
pp. 165-171
Author(s):  
Aleksey Belyaev ◽  
Georgiy Prokhorov ◽  
Anna Arkhitskaya

A review of the literature shows that surgical procedures will remain the standard treatment for primary bone tumors. Analysis of studies on the assessment of long-term results shows that additional double cryogenic treatment of the curettage cavity can improve the treatment outcomes of patients with giant cell tumors, dysplastic diseases and some forms of malignant lesions. The traditional execution of the procedure is associated with the open installation of liquid nitrogen in the bone cavity, which requires special skills in handling aggressive refrigerant from the staff and does not exclude complications. In case of multiple metastatic bone lesions, surgical treatment is not indicated. The recent emergence in clinical practice of new equipment with a closed liquid nitrogen circulation circuit inside cryoprobes resumes interest in cryoabla-tion of bone tumor lesions using modern minimally invasive puncture cryotechnology and expanding indications for its use in patients with severe comorbidities.


Sign in / Sign up

Export Citation Format

Share Document